Wladyslaw Pluta

Suggest Changes
Learn More
illes Montalescot, MD, PHD,* Stephen G. Ellis, MD,† Mark A. de Belder, MD,‡ uc Janssens, MD,§ Olivier Katz, MD, Wladyslaw Pluta, MD,¶ Patrick Ecollan, MD,* ichal Tendera, MD,# Ad J. van Boven, MD,**(More)
OBJECTIVES The aim of this study was to assess the risk-benefit of enoxaparin (Sanofi-Aventis, Paris, France) in primary percutaneous coronary intervention (PCI). BACKGROUND Randomized studies have(More)
  • 1